Status:
COMPLETED
Role of Neutrophils and Electro-bioluminescence in the Rehabilitation
Lead Sponsor:
MIPO Clinic
Conditions:
Nonsmall-cell Lung Cancer
Eligibility:
All Genders
40-65 years
Phase:
PHASE1
Brief Summary
The clinical study is to find out the effect of a course of immunomodulatory drugs and detoxification scheme on finger bioelectroluminescence and neutrophil function and their correlation with changes...
Detailed Description
Every year, 36,000 new cases of oncology are detected in Kazakhstan, and 14,150 people (39.3%) die from oncology in Kazakhstan each year. The lowest five-year survival rate for patients with lung canc...
Eligibility Criteria
Inclusion
- Clinical diagnosis Non-small cell lung cancer (histologically verified)
- Must be able to swallow tablets
- Detected for the first time
- Presence of all fingers and toes
- Patient must give their informed and signed consent
- Patient must be insured or have a health insurance plan.
- Clinically stable patients regardless of disease type.
- Absence of cognitive impairment; since the protocol provides for a clinical interview covering in particular his/her quality of life
Exclusion
- Decompensated forms of cancer (decompensation statuses of vital organs (pulmonary, cardiac, hepatic, renal, intestinal insufficiency);
- Clinical diagnosis other types of cancer, secondary tumors and lung metastases;
- Postoperative condition for lung tumor resection;
- Patient belongs to a vulnerable group;
- Patients with severe cognitive impairment;
- Tuberculosis of any localization in the active phase and in the anamnesis;
- Severe and decompensated course of endocrine diseases, including diabetes mellitus;
- Autoimmune diseases;
- Pregnancy and lactation period;
- Prisoners;
- Active military personnel;
- People without education;
- pensioners;
- People living below the poverty line or with limited access to health services.
- Unwillingness to participate in the study.
- Patient is participating in another study
- Patient with inability to complete our protocol evaluation scales
- Patients with symptoms that compromise their level of awareness
- Insulin dependent diabetes
- Thyroid disease
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2023
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT06209229
Start Date
May 1 2022
End Date
October 1 2023
Last Update
January 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MIPOClinic
Almaty, Kazakhstan, 050038